| Income Statement |
| Operating Expenses | 1.48M |
|
| Research and Development Expense | 703.00K |
| Selling, General and Administrative Expense | 778.00K |
| Operating Income | -1.48M |
| Interest Expense | 3.00K |
| Income Tax Expense | 1000 |
| Net Income | -3.26M |
| Net Income Common Stock | -3.26M |
| Net Income Common Stock (USD) | -3.26M |
| Consolidated Income | -3.26M |
| Earnings per Basic Share | -7.00 |
| Earnings per Basic Share (USD) | -7.00 |
| Earnings per Diluted Share | -7.00 |
| Earning Before Interest & Taxes (EBIT) | -3.25M |
| Earning Before Interest & Taxes (USD) | -3.25M |
| Weighted Average Shares | 470.21K |
| Weighted Average Shares Diluted | 470.21K |
| Balance Sheet |
| Cash and Equivalents | 3.69M |
| Cash and Equivalents (USD) | 3.69M |
| Investments | 6.21M |
| Investments Current | 6.21M |
| Current Assets | 10.36M |
| Total Assets | 10.36M |
| Current Liabilities | 675.00K |
| Total Liabilities | 675.00K |
| Accumulated Retained Earnings (Deficit) | -147.75M |
| Shareholders Equity | 9.68M |
| Shareholders Equity (USD) | 9.68M |
| Trade and Non-Trade Payables | 675.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 80.00K |
| Net Cash Flow from Financing | 4.55M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.88M |
| Issuance (Purchase) of Equity Shares | 1.57M |
| Issuance (Repayment) of Debt Securities | -101.00K |
| Net Cash Flow from Operations | -1.82M |
| Effect of Exchange Rate Changes on Cash | 747.00K |
| Share Based Compensation | 212.00K |